Literature DB >> 18695898

Characterization and gene expression analysis of novel matched primary and metastatic renal cell carcinoma cell lines.

Yoshio Ohno1, Miki Izumi, Masaaki Tachibana, Takeshi Kawamura, Kunihiko Yoshioka, Teiichiro Aoyagi, Makoto Ohori, Kazunori Namiki, Noboru Sakamoto, Yoshihiro Nakagami, Tadashi Hatano, Shingo Akimoto, Toshihide Nishimura.   

Abstract

Despite recent advances in molecular biology that have clarified the mechanisms involved in the metastasis of several types of cancer, the molecular mechanism underlying the metastasis of renal cell carcinoma (RCC) remains unclear. Two RCC cell lines were successfully established from the surgical specimens of a matched primary tumor and adrenal metastasis from the same RCC patient, and were designated as TMK-1P and TMK-1M, respectively. Extensive characterization was accomplished using various methods, including the Matrigel invasion assay, DNA microarray analysis and real-time reverse transcriptase (RT)-polymerase chain reaction (PCR). While TMK-1P grew faster than TMK-1M, the invasive ability of TMK-1M was higher than that of TMK-1P. DNA microarray analysis showed a large differential expression of genes related to cell adhesion and the extracellular matrix molecules of which hexabrachion (tenascin-C), epidermal growth factor receptor, cadherin-6, and beta1-catenin were down-regulated, and the 67 kDa laminin receptor 1 and transforming growth factor-beta-induced 68 kDa protein (betaig-h3) were up-regulated in TMK-1M. Real-time RT-PCR analysis confirmed this differential gene expression between the two cell lines. The RCC cell lines may be useful in studying tumor invasion and screening markers for metastasis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18695898

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  7 in total

1.  Tubulocystic renal cell carcinoma: is there a rational reason for targeted therapy using angiogenic inhibition? Analysis of seven cases.

Authors:  Petr Steiner; Milan Hora; Jan Stehlik; Petr Martinek; Tomas Vanecek; Fredrik Petersson; Michal Michal; Marie Korabecna; Ivan Travnicek; Ondrej Hes
Journal:  Virchows Arch       Date:  2013-01-08       Impact factor: 4.064

2.  Linkage of microRNA and proteome-based profiling data sets: a perspective for the priorization of candidate biomarkers in renal cell carcinoma?

Authors:  Barbara Seliger; Simon Jasinski; Sven P Dressler; Francesco M Marincola; Christian V Recktenwald; Ena Wang; Rudolf Lichtenfels
Journal:  J Proteome Res       Date:  2011-01-07       Impact factor: 4.466

3.  Transient variations in the serum concentrations of cell adhesion molecules following retroperitoneal laparoscopic and open radical nephrectomy for localized renal-cell carcinoma.

Authors:  Lu Yang; Tianyong Fan; Qiang Wei; Xiaobo Cui; Siyuan Bu; Ping Han
Journal:  J Endourol       Date:  2012-08-20       Impact factor: 2.942

4.  Metastasis-Initiating Cells in Renal Cancer.

Authors:  Mohammed I Khan; Anna M Czarnecka; Renata Duchnowska; Wojciech Kukwa; Cezary Szczylik
Journal:  Curr Signal Transduct Ther       Date:  2014-12

5.  Differential gene expression identifies KRT7 and MUC1 as potential metastasis-specific targets in sarcoma.

Authors:  Long Jiang; Bhairavi Tolani; Che-Chung Yeh; Yanying Fan; Joseph A Reza; Andrew E Horvai; Endi Xia; Johannes R Kratz; David M Jablons; Michael J Mann
Journal:  Cancer Manag Res       Date:  2019-09-09       Impact factor: 3.989

6.  Annexin II represents metastatic potential in clear-cell renal cell carcinoma.

Authors:  Y Ohno; M Izumi; T Kawamura; T Nishimura; K Mukai; M Tachibana
Journal:  Br J Cancer       Date:  2009-06-09       Impact factor: 7.640

Review 7.  Transforming growth Factor-Beta-Induced Protein (TGFBI)/(βig-H3): a matrix protein with dual functions in ovarian cancer.

Authors:  Miranda P Ween; Martin K Oehler; Carmela Ricciardelli
Journal:  Int J Mol Sci       Date:  2012-08-21       Impact factor: 6.208

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.